Kevin Cesa, MD

  • Fellow

Kevin is currently a first year Pediatric Gastroenterology, Hepatology, and Nutrition fellow at the Children's Hospital of Pittsburgh. The program is structured where the first year is entirely clinical and the next 2 years are 90% research. He was drawn to Pediatric GI to treat children with inflammatory bowel disease. Over the last decade there have been substantial advances in the treatment and management of IBD.  Specifically biologic medication has altered the course of the disease and changed the expectation of outcomes. Kevin plans on spending the next two years focusing on IBD research and more clinical exposure. Once he completes his fellowship his goal is to remain in academic medicine, so he can continue clinical research to better care for patients with IBD.

Professional and Scientific Society Memberships

  • American Academy of Pediatrics, 2015-Present
  • American Medical Association, 2015-Present
  • North American Pediatric Gastroenterologists, 2019-Present

Education & Training

  • BS, Chemistry, University of Pittsburgh, 2008
  • MD, Temple University Medical School, 2016
  • Internship and Residency in Pediatrics, University of Maryland Medical Center, 2016-2019
  • Fellowship, Pediatric Gastroenterology, Hepatology, and Nutrition, UPMC Children's Hospital of Pittsburgh, 2019-Present

Academic and Research Interests

Ndhlovu ZM, Proudfoot J, Cesa K, et al. Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses. Journal Virology. 2012 Jun. 86(12):6959-69

Chen H, Ndhlovu ZM, Liu D, Porter LC, Fang JW, Darko S, Brockman MA, Miura T, Brumme ZL, Schneidewind A, Piechocka-Trocha A, Cesa KT, et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nature Immunology. 2012 Jun 10. 13(7):691-700

Ndhlovu ZM, Chibnik LB, Proudfoot J, Vine S, McMullen A, Cesa K, et al. High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control. Blood. 2013 Jan 31. 121(5):801-11

Gaiha GD, McKim KJ, Woods M, Pertel T, Rohrbach J, Barteneva N, Chin CR, Liu D, Soghoian DZ, Cesa K, et al. Dysfunctional HIV-specific CD8+ T cell proliferation is associated with increased caspase-8 activity and mediated by necroptosis. Immunity. 2014 Dec 18. 41(6):1001-12

Li JZ, Arnold KB, Lo J, Dugast AS, Plants J, Ribaudo HJ, Cesa K, et al. Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics. Open Forum Infect Dis. 2015 Jan 13;2(1):ofu117.

Ndhlovu ZM, Stampouloglou E, Cesa K, Mavrothalassitis O, Alvino DM, et al. The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers. J Virol. 2015 Nov;89(21):10735-47. doi: 10.1128/JVI.01527-15